A, A. (2026). Report of the multistakeholder drug development round table meeting of the World Duchenne Organization focusing on challenges for clinical development of therapies. Journal of neuromuscular diseases, 13(4), 850. https://doi.org/10.1177/22143602251399511
Chicago Style (17th ed.) CitationA, Aartsma-Rus. "Report of the Multistakeholder Drug Development Round Table Meeting of the World Duchenne Organization Focusing on Challenges for Clinical Development of Therapies." Journal of Neuromuscular Diseases 13, no. 4 (2026): 850. https://doi.org/10.1177/22143602251399511.
MLA (9th ed.) CitationA, Aartsma-Rus. "Report of the Multistakeholder Drug Development Round Table Meeting of the World Duchenne Organization Focusing on Challenges for Clinical Development of Therapies." Journal of Neuromuscular Diseases, vol. 13, no. 4, 2026, p. 850, https://doi.org/10.1177/22143602251399511.